Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial

R. Spigel, David; Westeel, Virginie; C. Anderson, Ian; Greillier, Laurent; Guisier, Florian; Bylicki, Olivier; Badin, Firas; Rousseau-Bussac, G.; Deldycke, Clotilde; Griesinger, Frank; J. Bograd, Adam; Zhong, Wangjian; Le Treut, J.; Van Hulst, Sylvie; R. Gandara, David; Reck, Martin; Hoffknecht, Petra; A. Gubens, Matthew; Crowley, John; von der Leyen, Heiko; A. Woodard, Gavitt; M. Jablons, David; R. Kratz, Johannes; J. Mann, Michael; J Mann, Michael; J Mann, Michael; R. Spigel, David; Westeel, Virginie; C. Anderson, Ian; Greillier, Laurent; Guisier, Florian; Bylicki, Olivier; B. Badin, Firas; Rousseau-Bussac, Gaelle; Deldycke, Clotilde; Griesinger, Frank; Bograd, Adam; Zhong, Wangjian; Le Treut, Jacques; Van Hulst, Sylvie; R. Gandara, David; Reck, Martin; Hoffknecht, Petra; A. Gubens, Matthew; Crowley, John; von der Leyen, Heiko; A. Woodard, Gavitt; M. Jablons, David; R. Kratz, Johannes; R. Kratz, Johannes; J. Mann, Michael; J. Mann, Michael; Aigner, Clemens; Bauer, Thomas; Berndt, Célia; Besse, Benjamin; Bohnet, Sabine; Bombaron, Pierrre; Bubis, Jeffrey; Buchmeier, Eva; Cadranel, Jacques; Chay, Christopher; Chua, Winston; Clary, Carolyn; Dalia, Samir; Debieuvre, Didier; Donegan, Shaun; Eberhardt, Wilfried; Galland-Girodet, Sigolène; Giroux Leprieur, Etienne; Golpon, Heiko; Guibert, Cyril; Hureaux, Jose; Jouveshomme, Stéphane; Kurkijian, Carla; Le Floch, Hervé; Legras, Antoine; Mazieres, Julien; Morin, Franck; Patel, Vijay; Peles, Shachar; Percent, Ivor; Reinmuth, Niels; Schneider, Sophie; Sleckman, Bethany; Tufman, Amanda; Weksler, Benny; Wislez, Marie; Yang, Xeuzhong; Zalcman, Gérard; Zysman, Maéva

doi:10.1016/s2213-2600(25)00213-9

Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial | NobleBlocks